2seventy Bio price target lowered to $5 from $6 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on 2seventy Bio (TSVT) to $5 from $6 and keeps an Equal Weight rating on the shares following ...
Medical Dialogues13 小时
Bristol Myers Squibb to acquire 2seventy bio for USD 286 million
Cambridge: 2seventy bio, Inc. has announced a definitive merger agreement under which Bristol Myers Squibb will acquire all ...
美股内部交易 | 2seventy bio于3月13日披露3笔公司内部人交易情况
2025年3月13日， 2seventy bio（TSVT）披露3笔公司内部人交易情况。持股10%以上股东Kynam Global Healthcare Master Fund, LP于2025年3月11日卖出595.38万股。 2025年3月13日 持股10%以上股东 Kynam Global Healthcare Master Fund, LP 2025年3月11日 卖出 1623.80万 4 ...
S&P 500 Gains and Losses Today: Index Bounces Off Lows as Government Shutdown Concerns Ease
Key Takeaways The S&P 500 jumped 2.1% on Friday, March 14, wrapping up a volatile week as government shutdown concerns ...
Europe Approves Bristol Myers' Cell Therapy Breyanzi For Patients With Certain Type Of ...
EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...
Bristol Myers announces EC approval of Breyanzi
Squibb announced that the European Commission has granted approval to Breyanzi, a CD19-directed chimeric antigen receptor T ...
Reuters23 小时
Global Market Headlines | Breaking Stock Market News | Reuters
People walk past the Nasdaq market site as U.S. stock markets opened Tuesday following Monday’s broad sell-off in New York City, U.S., March 11, 2025. REUTERS/Mike Segar/File photo ...
Indiatimes23 小时
Nath Bio-Genes (India) Share Price
Company has Ashok R Majethia & Co. as its auditors. As on 31-12-2024, the company has a total of 1.90 Crore shares outstanding.Nath Bio-Genes Share Price Today is Rs. 147.63. On previous day, the Nath ...